NCT02718937View on ClinicalTrials.gov

Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Respiratory Syncytial Virus (RSV) Infection
Interventions
DRUG

BTA-C585 oral capsule

DRUG

Matching placebo capsules

Trial Locations (1)

E1 2AX

Biota Investigational Site, London

All Listed Sponsors
lead

Biota Pharma Europe Limited

INDUSTRY

NCT02718937 - Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study | Biotech Hunter | Biotech Hunter